Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Post-Traumatic Osteoarthritis: Managing OA That Develops After Joint Injuries & Reconstructive Surgery

Susan Bernstein  |  Issue: February 2019  |  November 28, 2018

Tom Appleton, MD, PhD

Tom Appleton, MD, PhD

CHICAGO—Joint trauma is one of many potential drivers of osteoarthritis disease activity and structural progression. In Post-Traumatic OA: Pathogenesis, Clinical Evolution and Management, a session at the 2018 ACR/ARHP Annual Meeting, experts discussed the effects of sports and other injuries on even young patients’ joints.

Post-traumatic osteoarthritis (OA) may account for 12% of hip, knee and ankle OA cases, and in this form of knee OA, “biomechanics [are] important, as well as malalignment, gait abnormalities and tissue-specific effects,” said Tom Appleton, MD, PhD, assistant professor of medicine, Western University in London, Ontario, Canada.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

OA may develop following injury due to unresolved inflammation, hemarthrosis, chronic destabilization and biomechanical effects of the trauma on cartilage and other tissues. Catabolic responses, such as tissue necrosis and acute innate inflammation that never completely resolves, occur shortly after trauma, followed by anabolic responses, including bone remodeling and extracellular matrix (ECM) synthesis.2 Three weeks after anterior cruciate ligament (ACL) tears, patients have elevated cytokines in their synovial fluid.3 Lubricin, a glycoprotein secreted from synovial fibroblasts, may slowly resolve, and inflammatory markers, such as TNF-α or IL-6, may stay elevated.4

“Does severity of the joint injury matter in terms of pathophysiology and overall risk?” asked Dr. Appleton. Osteochondral fractures may lead to cytokine levels elevated in comparison with soft-tissue injury alone, suggesting more injury leads to more inflammation. More severe intra-articular fractures led to more severe synovitis in one study in mice, but “it didn’t translate to any worse damage in terms of the cartilage nor an increase in cell death.5 So it may depend, in a tissue-specific way, on how intense the injury to the cartilage in the joint is.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

‘Soft tissues are important sources of proteases that are known to damage cartilage & joint structures.’ —Tom Appleton, MD, PhD

Severe, repetitive loading may cause dose-dependent changes to cartilage and synovial lining.6 Hemarthrosis after a knee injury may lead to leukocyte activation and reactive oxygen species (ROS) production even in an otherwise healthy person, and this acute, substantial joint bleeding can damage knee cartilage, much more so than microbleeds.7,8

“What about effects on other joint tissues, such as the soft tissues?” asked Dr. Appleton. Gottingen minipigs showed elevated levels of matrix metalloproteinases (MMP) 1, 13 and the aggrecanase ADAMTS-4 in both their cartilage and ligament tissue after ACL injuries in one study.9 “These soft tissues are important sources of proteases that are known to damage cartilage and joint structures.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:American College of RheumatologyConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:2018 ACR/ARHP Annual Meeting

Related Articles

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    New Therapeutics for Osteoarthritis May Be in Sight

    April 1, 2015

    Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible

    Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage

    November 28, 2018

    CHICAGO—Are effective treatments for osteoarthritis (OA) on the horizon? In Emerging Treatments for Osteoarthritis at the 2018 ACR/ARHP Annual Meeting, experts discussed potential therapies to address OA structural progression, pain and inflammation. With an aging population and rising obesity rates, “we can expect the prevalence of osteoarthritis will only increase,” said Anne-Marie Malfait, MD, PhD,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences